Annexon reports inducement grants to new employees under nasdaq listing rule 5635(c)(4)

Brisbane, calif., aug. 16, 2024 (globe newswire) -- annexon, inc. (nasdaq: annx), a biopharmaceutical company advancing novel complement therapies for neuroinflammatory diseases of the body, brain and eye, today announced that it has granted inducement to two new non-executive employees under the terms of the 2022 employment inducement award plan. the equity awards were approved on august 15, 2024, in accordance with nasdaq listing rule 5635(c)(4).
ANNX Ratings Summary
ANNX Quant Ranking